chemotherapy-induced anaemia
Oncology · 2007–2019
3decisions
1medicine
0carried consumer input
0individual submissions
No submission for this condition has carried consumer input, including the one made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| darbepoetin alfa Treatment of moderate to severe chemotherapy-induced anaemia in patients receiving myelosuppressive chemotherapy for non-myeloid malignancies with haemoglobin… | Mar 2019 | Not recommended | none received |
| darbepoetin alfa Treatment of chemotherapy induced anaemia (CIA) in patients with non-myeloid malignancies who meet certain criteria, as per the TGA-registered indication for… | Nov 2007 | Not recommended | no section in document |
| Darbepoetin alfa Treatment of chemotherapy induced anaemia (CIA) in patients with non-myeloid malignancies who meet certain criteria, as per the TGA registration for treatment… | Nov 2007 | Not recommended | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.